Sabus Steve M 4
4 · Syndax Pharmaceuticals Inc · Filed Dec 5, 2022
Insider Transaction Report
Form 4
Sabus Steve M
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to buy)
2022-12-05$25.44/sh+220,000$5,596,800→ 220,000 totalExercise: $25.44Exp: 2032-12-05→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the total number of shares underlying the option shall vest on December 5, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.